The US Food and Drug Administration has cleared Airway Management’s Nylon flexTAP, a digitally printed single-point midline oral appliance device for mild to moderate obstructive sleep apnea (OSA). Manufactured in the United States, the device is now available through Airway Labs, with PDAC coverage (E0486) pending. According to Airway Management, key features include:Digitally-printed medical-grade nylon: Utilizes advanced digital printing for a precise, custom-fit design that prioritizes patient comfort. “We are thrilled to introduce the Nylon flexTAP, a game-changer in oral appliance therapy,” says Charles Collins, CEO of Airway Management, in a release. “Feedback from key opinion leaders in our TAP Sleep Care system highlights its superior effectiveness and patient comfort.